Bringing the fundamentals into focus…
Back to ADMA Biologics, Inc.
How ADMA Biologics, Inc. stacks up
ADMA · against 1,216 other Healthcare companies
Growth
67/ 100
Above the middle of the pack.
Ranked #397 of 1,217 · scores higher than 67% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 60–69, including ADMA · Click a bar to see the companies
Why growth scores 67?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
- slower growth in earnings per share: weaker than 80% of peers. Earnings per share growth: -25.9% vs peer median 9.8%
- Revenue growth is close to the peer norm. Revenue growth: 8.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 89% of peers. 3-year revenue growth: 35.0% vs peer median 5.8%
Metric by metric
Position: dot = ADMA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ADMA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 8.0% | 6.1% | 56% | 33% | |
| Earnings per share growthHigher is better · 682 reported | -25.9% | 9.7% | 20% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 35.0% | 5.8% | 89% | 33% |
Ranking by growth score
Top 5 and the companies ranked around ADMA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 385 | 1.77T INR (≈$21.2B) | 68 | 57 | |
| 397 | 4.5B HKD (≈$579M) | 67 | 54 | |
| 397 | 62.7B JPY (≈$426M) | 67 | 40 | |
| 397 | 1.1B MYR (≈$245M) | 67 | 70 | |
| 397 | 2.5B USD | 67 | 79 | |
| 397 | 2.4B USD | 67 | 64 | |
| 397 | 21.5B DKK (≈$3.2B) | 67 | 58 | |
| 397 | 15.7B SEK (≈$1.6B) | 67 | 51 | |
| 397 | 289M USD | 67 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score